Sort
50,496 grants matching “lung cancer”
Mechanisms of non-IgE Mast Cell Activation by Environmental Particulates
$515,084Jared Michael Brown · University Of Colorado Denver · R01 · FY2020 · ES
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
$515,071Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2016 · CA
Particulate Cr(VI) Toxicology in Human Lung Epithelial Cells and Fibroblasts
$515,069John Pierce Wise · University Of Louisville · R01 · FY2020 · ES
Project 2: The Impact of Immunotherapy on Human Vaccination
$515,006E. John Wherry · Massachusetts General Hospital · U19 · FY2020 · AI
Targeting Lymph Node Dependent Immune Tolerance in Cancer
$514,984Edgar G. Engleman · Stanford University · R01 · FY2024 · CA
Effects of Klotho protein on aging and metabolism
$514,960Makoto Kuro-O · Ut Southwestern Medical Center · R01 · FY2009 · AG
Extracellular Matrix in the Innate Response in Lung Inflammation
$514,947Thomas N Wight · Benaroya Research Inst At Virginia Mason · P01 · FY2010 · HL
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$514,902Donald P McDonnell · Duke University · R01 · FY2024 · CA
MOLECULAR EPIDEMIOLOGY OF LUNG CANCER
$514,881Chu Chen · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma
$514,791David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Modular design of multiscale models, with an application to the innate immune response to fungal respiratory pathogens.
$514,632Reinhard Laubenbacher · University Of Connecticut Sch Of Med/Dnt · U01 · FY2019 · EB
Cancer Genetics of Short Telomere Syndromes
$514,604Mary Y. Armanios · Johns Hopkins University · R01 · FY2019 · CA
Targeting APOBEC3-induced squamous differentiation in bladder cancer
$514,582William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Ultrasound Imaging and Therapy for Prostate Cancer
$514,534Focus Surgery, Inc. · R44 · FY2003 · DK
Targeting the Epigenome for Lung Cancer Therapy
$514,430David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells
$514,430David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Epigenetic Alterations Induced by Tobacco Smoke
$514,430David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$514,430David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
$514,415Daniel William Cramer · Brigham And Women'S Hospital · R01 · FY2013 · CA
Probing the mechanisms of dependency underlying skeletal genetic pathways of p53 and Notch in the pathogenesis of osteosarcoma
$514,405Jianning Tao · Sanford Research/Usd · R01 · FY2025 · CA
Immunology Team Contributions to the LSB
$514,339Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$514,297Alejandro V Villagra · Georgetown University · R01 · FY2022 · CA
Precision Antibody Imaging & Radiotherapy of Solid Tumors
$514,252Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2021 · CA
Target discovery and combination therapy in KRAS mutant cancer
$514,251Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Organoid models of KRAS mutant cancer
$514,251Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA